Márquez-Arrico, Cecilia Fabiana https://orcid.org/0000-0002-0185-6180
Pelechá-Salvador, María
López-Domènech, Sandra
Fernández-Reyes, Meylin
Silvestre, Francisco Javier
Silvestre-Rangil, Javier
Montiel-Company, José María
Rocha, Milagros
Funding for this research was provided by:
HORIZON EUROPE EU Programme (101136516)
HORIZON EUROPE EU Programme (101136516)
Carlos III Health Institute (CD23/0006)
Carlos III Health Institute (PI22/01009, PI25/01841)
European Regional Development Fund
Valencian Government, Ministry of Education, Culture, Universities, and Employment (CIGE/2024/82)
Valencian Government, Ministry of Education, Culture, Universities, and Employment (CIPROM/2022/32)
Article History
Received: 27 April 2026
Accepted: 1 July 2026
First Online: 10 July 2026
Declarations
:
: This study was conducted in strict accordance with the ethical principles outlined in the Declaration of Helsinki for research involving human subjects. All procedures were approved by the “Research Ethics Committee for Medicines” (CEIm) of the Doctor Peset University Hospital in Valencia (approval document nº Ceim 31/19, registered under NCT06184412). Written informed consent and a signed confidentiality agreement were obtained from all participants in the study who voluntarily participated.
: Not applicable.
: The authors declare no competing interests.